Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

A Phase 4, Open-Label, Non-randomized, Multicenter Study to Evaluate Safety and Efficacy of Intravenous Administration of OPTISON for Contrast- Enhanced Echocardiography in Pediatric Patients

Trial Profile

A Phase 4, Open-Label, Non-randomized, Multicenter Study to Evaluate Safety and Efficacy of Intravenous Administration of OPTISON for Contrast- Enhanced Echocardiography in Pediatric Patients

Not yet recruiting
Phase of Trial: Phase IV

Latest Information Update: 15 Feb 2019

At a glance

  • Drugs Perflutren (Primary)
  • Indications Left ventricular dysfunction
  • Focus Diagnostic use
  • Sponsors GE Healthcare
  • Most Recent Events

    • 07 Feb 2019 Planned initiation date changed from 1 Jan 2019 to 1 Jun 2019.
    • 21 Nov 2018 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top